2022 Chemo Cards (Chemotherapy & Targeted Therapies Subcommittee)
The SGO and the Chemotherapy & Targeted Therapy Subcommittee of the SGO Education Committee have updated the 2022 Chemotherapy & Targeted Therapy flash cards that highlight therapies and offer a “refresher” on dosing, side effects, contraindications, and more. Flash cards are available as printable PDFs for quick reference in-clinic.
Included in this resource are individual PDFs on the following:
- Adavosertib
- Anastrozole
- Atezolizumab
- Avelumab
- Bastilimab
- Bevacizumab
- Cediranib
- Cemiplimab
- Dostarlimab
- Durvalumab
- Everolimus
- Erlotinib
- Exemestane
- Fulvestrant
- Iplimumab
- Ixbepilone
- Letrozole
- Levonorgestrel
- Medroxyprogesterone acetate
- Megestrol acetate
- Mirvetuximab
- Metformin
- Nivolumab
- Oxaliplatin
- Oxaliplatin Capecitabine
- Palbociclib
- Pazopanib
- Pembrolizumab
- Pemrolizumab Lenvatinib
- Ribociclib
- Tamoxifen
- Temsirolimus
- Tisotumab
- Trabectedin
- Trametinib
- Trastuzumab
- Zalifrelimab
Keywords: Chemotherapy, targeted therapy, clinical practice, immunotherapy, targeted, flash cards
Target Audience
Physicians, APPs, NPs, RNs